Previous close | 100.55 |
Open | 100.40 |
Bid | 100.55 x 50000 |
Ask | 101.45 x 50000 |
Day's range | 100.40 - 100.55 |
52-week range | 96.20 - 133.80 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is one...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdikar, President, Chief Executive Officer and a member of the board of directors of Embecta Corp. (embecta), has been appointed to the Zimmer Biomet Board, effective immediately. embecta (Nasdaq: EMBC), formerly part of Becton, Dickinson and Company (BD), is one of the largest pure-play diabetes management companies in the world.
The board of Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) has announced that it will pay a dividend of $0.24 per share on...